PBLS (Parabilis Medicines, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by PBLS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Craig Tendler | Director | A | — | — |
| 2026-07-22 | RA Capital Healthcare Fund LP | Director | Buy | — | — |
| 2026-06-29 | Soleus Capital Management, L.P. | 10%+ Owner | MIXED | — | — |
| 2026-06-16 | ALAN SEBULSKY | Director | Buy | — | — |
| 2026-06-15 | ALAN SEBULSKY | Director | Buy | — | — |
| 2026-06-15 | Alexis Borisy | Director | C | — | — |
| 2026-06-15 | EDWARD M FITZGERALD | Director | C | — | — |
| 2026-06-15 | Rajeev M. Shah | Director | MIXED | — | — |
| 2026-06-11 | Richard Klausner | Director | A | — | — |
| 2026-06-11 | Alexis Borisy | Director | A | — | — |
| 2026-06-11 | Barbara Weber | Director | A | — | — |
| 2026-06-11 | ALAN SEBULSKY | Director | A | — | — |
| 2026-06-11 | Jake Simson | Director | A | — | — |
| 2026-06-11 | EDWARD M FITZGERALD | Director | A | — | — |
| 2026-06-11 | Krishna Yeshwant | Director | A | — | — |
| 2026-06-11 | Rajeev M. Shah | Director | A | — | — |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P. | 10%+ Owner | C | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 26,444,713 | — |
| — | Director | 26,285,093 | — |
| — | 10%+ Owner | 533,220 | — |
| — | 10%+ Owner | 527,070 | — |
| — | Director | 105,414 | — |
| — | Director | 25,935 | — |
| — | Director | 14,688 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PBLS quote page; the site-wide leaderboard is on the insider transactions hub.